The U.S. Food and Drug Administration (FDA) has approved Onapgo (apomorphine hydrochloride) injection, the first and only ...

Supernus Pharmaceuticals' FDA approval for ONAPGO in Parkinson's Disease offers optimism despite past challenges, with a ...

Insulin pump market growth is propelled by advancements in technology, rising global diabetes prevalence, and increased demand for precision diabetes management.New Delhi, Feb. 06, 2025 (GLOBE ...

PORTLAND, IL, UNITED STATES, February 6, 2025 /EINPresswire / -- Alarming rise in prevalence of disorders such as cancer and diabetes, rise in healthcare expenditures, rise in government & private ...

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

The lack of awareness about rare diseases like prurigo nodularis and available treatment options is anticipated to impede market growth.

Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. | The device is ...

Despite strong revenue growth, Baxter struggles with profitability and high long-term debt. Click here to read why BAX stock ...

MRI-Compatible IV Infusion Pump Systems MarketThe global market for MRI-compatible IV infusion pump systems is set for significant expansion, driven by advancements in medical imaging and increasing ...

UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...

Men undergoing radiation therapy for prostate cancer who experience side effects early in treatment may face a ... determine whether donor lymphocyte infusion (DLI), a standard therapy for ...

The growing geriatric population will further boost the adoption of pain monitoring devices and will lead to an increase in ...